Harrow Health, Inc. (NASDAQ:HROW) Major Shareholder Opaleye Management Inc. Buys 29,400 Shares

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) major shareholder Opaleye Management Inc. purchased 29,400 shares of Harrow Health stock in a transaction dated Friday, April 19th. The shares were acquired at an average cost of $10.56 per share, for a total transaction of $310,464.00. Following the transaction, the insider now directly owns 3,775,000 shares […]

Related Keywords

Craig Hallum ,Institutional Trading Of Harrow Health ,Eton Pharmaceuticals Inc ,Harrow Health ,Envestnet Asset Management Inc ,Surface Ophthalmics Inc ,Securities Exchange Commission ,Nasdaq ,Wasatch Advisors Inc ,Opaleye Management Inc ,Harrow Health Inc ,Prelude Capital Management ,Pharmaceuticals Inc ,Quarter For Harrow Health ,Harrow Health Stock Down ,News Ratings For Harrow Health Daily ,Blackrock Inc ,Get Free Report ,Opaleye Management ,Exchange Commission ,Health Stock Down ,Asset Management ,Capital Management ,State Street Corp ,Street Corp ,Surface Ophthalmics ,Melt Pharmaceuticals ,Eton Pharmaceuticals ,Harrow Health Daily ,Nasdaq Hrow ,Throw ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,